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Abstract
Mozambique has one of the highest burdens of HIV globally, and people who inject drugs (PWID) have one of the
highest HIV infection rates in Africa. After the implementation of the first Biological Behavioral Surveillance (BBS)
Survey among PWID in Mozambique, the Ministry of Health started the development of a National Harm Reduction
Plan. Although the findings from the BBS survey highlighted the specific needs of young PWID, the proposed Harm
Reduction Plan does not explicitly focus on reducing high-risk behaviors of young PWID. We outline the importance of the
inclusion of age-specific interventions focused on the needs of young PWID in Mozambique, and how a comprehensive
Harm Reduction Plan can reduce the HIV epidemic in this population. There is a unique opportunity to advocate for the
Harm Reduction Plan to include “youth-friendly” cost-effective and evidence-based interventions that are targeted to this
important sub-group within an already vulnerable population.
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Background
The period of adolescence and youth aged 10–24 years
is typically characterized by experimentation, new expe-
riences, and social vulnerability. Evidence suggests that
people who inject drugs (PWID) often begin injecting at
a young age [1–3]. Young people face tremendous chal-
lenges to access HIV and sexual and reproductive health
services, including inequalities, discrimination, exclusion,
and violence. Yet, the global response to HIV among
PWID largely neglects this critical key sub-population
who benefit less than other groups from established ser-
vice provision models [4]. Drug use behaviors usually
emerge as a result of interaction between environmental
and social determinants and development process.
Many young PWID do not like accessing health services
alongside adult PWID because they feel that they have
little in common with the adult PWID who generally ac-
cess services [1, 2]. Additionally, HIV service providers are
often inadequately trained to support youth with sex edu-
cation, reproductive services, drug use counseling social
services, violence prevention, and other youth-specific
health concerns [5, 6]. On the other hand, the staff of pro-
grams for young people may lack the sensitivity, know-
ledge, and training to work specifically with youth from
key populations [2, 6, 7]. The criminalization of drug use,
combined with the high levels of stigma and discrimin-
ation related to the illicit nature of this practice, further
increases their susceptibility to blood-borne and sexually
transmitted infections (STI) and HIV and viral hepatitis (B
and C) [1, 3, 8]. The lack of integrated services for HIV,
TB, viral hepatitis, STIs, and related to harm reduction
hampers the health care seeking in youth population [6].
Neglecting to identify the specific and comprehensive
health needs of this key sub-population, and their particu-
lar barriers to health care, has the potential to
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compromise the success of HIV prevention and control
programs targeted to those specific populations [4, 9].
Around one-quarter of the world’s population are
youth, and nearly 160,000 of new HIV infections globally
in 2018 occurred in under 15 age [6, 10]. The overall
burden of HIV in the Sub-Saharan African region attrib-
uted to injection drug use is limited, and specific data
about young PWID remain largely invisible in routine
HIV surveillance and surveys. This has a major conse-
quence on the effectiveness of harm reduction policies
and programs since they are largely designed for adult
PWID [11].
The results from the first Biological Behavioral Surveil-
lance (BBS) survey conducted in 2013–2014 in two
urban areas in Mozambique revealed a high prevalence
of HIV estimated to be 50.1% (95% CI, 40.1–59.0) in
Maputo and 19.9% (95% CI, 10.9–29.2) in Nampula/Na-
cala [12]. Given this high burden of disease, PWID were
recognized by the Mozambique National Strategic HIV/
AIDS Response Plan (2015–2019) as a high-risk group
for HIV due to their specific risk behaviors, such as
sharing contaminated syringes and unprotected sex [13].
After the implementation of the first PWID BBS in
Mozambique, the Ministry of Health (MoH) started the
development of a National Harm Reduction Plan, under
the umbrella of the National Strategy for Mental Health
(2016–2026). The main objective of the plan is to
address public health problems caused by drug use, re-
duce risks, and prevent disease. However, thus far, the
discussions around the plan’s development have not
considered the unique needs of adolescents and young
people nor expanded on how the plan could be adapted
to ensure that public health services reach this age
group.
International concerns of youth drug use in the HIV
epidemic
On a global scale, attention has also focused on im-
proving the quality of services for PWID. There have
been various international declarations and commit-
ments with specific goals and targets for young
people. In 2016, UN members states adopted the fast
track targets aimed to end the global HIV epidemic
by 2030. The Political Declaration on HIV and AIDS
recognized the critical role of young people in the
global HIV epidemic, the inadequate integration of
health services, and a set of specific time-frame tar-
gets with more young gender-inclusive approach [14].
Although some countries have achieved a general
decline in HIV prevalence over the years, such reduc-
tions could not be systematically linked to specific
programmatic interventions, due to the absence of
operational targets and inadequate surveillance
systems [15].
The World Health Organization (WHO), United Na-
tions Office of Drugs and Crime (UNODC), and the
Joint United Nations Programme on HIV/AIDS
(UNAIDS) developed a comprehensive package of Harm
Reduction Services for preventing the spread of HIV and
reducing other harms associated with drug use. The
technical guidance outlines a comprehensive package of
interventions for the prevention, treatment, and care of
HIV infection among PWID; provides a set of indicators
to monitor and evaluate the implementation and impact
of these interventions; advises on setting targets for
scale-up to maximize the impact of HIV prevention and
care among PWID; and provides examples of data
sources and useful tools to assist with program develop-
ment, implementation, monitoring, and evaluation [16].
However, even these various global guiding documents
lack specific recommendations for youth, which is a
missed opportunity given that these risk behaviors are
often developed during adolescence and youth and that
the consequences of the behaviors contribute to the
burden of disease among this age-group [1, 3, 17].
Young PWID in Mozambique
Young people, who make up 32.5% of the Mozambican
population [18], are a vulnerable sub-population of the
country’s HIV epidemic. Data from the population-
based 2015 National AIDS Indicator Survey (IMASIDA)
results show relatively low levels of knowledge about
HIV in young people with 7 in every ten not having a
comprehensive knowledge of HIV. Among young men,
comprehensive HIV knowledge decreased by 22% since
the last household survey conducted in 2011. The HIV
prevalence among young people aged 15–24 was 6.9%,
where it was higher in young women (9.8% vs. 3.2%).
Also, 3% of young women and 18% of young men report
having had two or more partners in the last 12 months,
and less than 50% of youth reported condom use during
their last sexual intercourse. Among participants 15–24
years of age who had sex in the last 12 months, only 38%
of women and 18% of men were tested in the last 12
months and received the result of the last test [19].
These vulnerabilities are heightened among young
PWID.
Data from the first BBS in Mozambique show that
HIV prevalence among PWID aged 18–24 in Maputo
was 18.8%. Nearly half of PWID (46.1% for Maputo and
48.2% for Nampula/Nacala) had their first contact with
drugs when they were 18–24 years of age. Young PWID
also reported high-risk sexual and drug use behaviors.
Among sexually active young PWID who injected drugs
in the last 12 months, only 44.4% in Maputo and 32.5%
of PWID in Nampula/Nacala used a condom during
their last intercourse. Less than 70% (66.5% for Maputo
and 67.3% in Nampula/Nacala) reported using brand
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new injection equipment during their last drug injection.
Among younger PWID unaware of their status, HIV
testing was low, with only 22.4% and 20.2% in Maputo
and Nampula/Nacala, respectively, tested for HIV in the
12months before the survey [20].
Programmatic and political gaps in services for PWID
The Sub-Saharan Africa region is far behind in imple-
menting and scaling-up harm reduction interventions rec-
ommended by the United Nations; similarly, efforts are far
below estimates required to reverse the HIV epidemic
among PWID in the region [17, 21]. According to the
most recent Global State of Harm Reduction publication,
only 11 countries have policies that specifically advocate
for harm reduction activities. In the specific case of
Mozambique, there is only one operational needle and
syringe program [22]. The political and legal environment
in Sub-Saharan Africa continues to follow a predomin-
antly punitive approach when considering harm reduction,
and only a few countries in the region include an explicit
supportive reference to harm reduction in their national
policies and programs on HIV or drugs [6].
Substance abuse services for PWID in Mozambique
are integrated into programs managed by the National
Mental Health Program. The 2017 National Mental
Health Program Report indicates that 10,120 patients
attended the health services due the drug use, of which
more than 50% were under 30 years of age [23]; how-
ever, current data systems do not specifically outline the
age or sex disaggregation of these young patients. Dur-
ing qualitative interviews conducted as part of the BSS,
PWID Mozambique listed the co-location of substance
abuse services within mental health services as a barrier
to treatment because of the stigma associated with seek-
ing psychiatric support [20]. As such, it is likely that less
youth access services than are actually in need.
In 2018, the MoH developed the Integrated Guidelines
for Prevention, Care and Treatment services of the HIV
and AIDS for Key Populations in the Health Sector to en-
sure that key populations had access to high-quality,
evidence-based services. The strategy was gradually im-
plemented in 22 health facilities with plans to expand to
all antiretroviral treatment (ART) sites in 2020. These
guidelines provide an orientation to the HIV-related
program managers and health providers on the integra-
tion of health services to serve key populations, includ-
ing PWID; however, they do not include additional
guidance for the focus on youth PWID.
The Mental Health Program is currently drafting a
National Harm Reduction Plan based on global guidance
which advocates for appropriate medication-assisted
therapy; injection equipment programs and antiretroviral
therapy to prevent the transmission of HIV, viral hepa-
titis, and other blood-borne viruses; and also underlines
the need for the full respect of the human rights and
fundamental freedoms of people who use drugs [24].
Opportunities for the integration of young PWID in the
National Harm Reduction Plan: recommendations
It is imperative that the Mozambique Mental Health
Program incorporate the specific needs of youth in the
drafting of the National Harm Reduction Plan, given the
available data about the specific vulnerability of youth
and PWID.
Reaching young people before they start injecting is a
window of opportunity to prevent drug initiation, HIV
infection, and other sexually transmitted infections.
Harm reduction strategies can benefit both HIV negative
and positive young PWID to prevent HIV acquisition
and ongoing transmission among those not yet infected
and to maintain health, promote adherence to HIV
treatment, and reduce the risk of onward transmission
[25]. The school context is an excellent environment to
advocate and introduce youth harm reduction ap-
proaches to prevent substance abuse [26, 27].
Evidence shows that improved access to health ser-
vices for young people might help to prevent the social,
educational, and economic risks of problematic sub-
stance use [4]. Moreover, special attention must also be
given to the additional vulnerability of gender, such as
female PWID who also report sex work in exchange for
drugs [28].
The forthcoming Harm Reduction Plan should high-
light the multidimensional approach to supporting
young PWID since a comprehensive package of harm re-
duction interventions for this sub-population cannot
exist in a vacuum. Strategies must promote collaboration
between mental health and adolescent health programs
to ensure that youth-friendly health services support
young PWID with assessing critical interventions such
as access to condoms, HIV counseling and testing, and
sexual and reproductive health services (including diag-
nosis and treatment of STIs). Needle/syringe distribution
programs should also be prepared to understand the
specific needs of young PWID and ensure an environ-
ment free of stigma and discrimination. High coverage
of integrated prevention and treatment services for
youth sustained overtime is necessary to achieve lasting
gains in the prevention of HIV infection in youth
PWID [29].
Another important aspect is to strengthen the collab-
oration between community-based and health facility
services for an effective coordination of comprehensive
youth health programs. A monitoring and evaluation
system that captures indicators that can be disaggregated
for youth will help program managers and decision-
makers to assess the effectiveness of interventions for
this specific age-group. This strategic information should
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detect bottlenecks or gaps to service implementation,
guide a targeted response, and provide the information
necessary to evaluate the implementation and impact of
the Harm Reduction Plan among youth.
Finally, the effective uptake of services by young PWID
requires their meaningful engagement and leadership.
Youth are more likely to adopt services when they partici-
pate in the development and implementation of policies,
programs, and interventions that focus on their health and
affect their lives. Youth can make substantial contributions
to a stronger community-led response to the HIV epi-
demic when they are empowered with adequate skills and
resources to contribute and participate [9].
Conclusions
Young people face tremendous challenges to access HIV
and sexual and reproductive health services, including
inequalities, discrimination, exclusion, and violence. More
efforts are needed to ensure that young people are not left
behind. The current drafting of the National Harm
Reduction Plan is an opportune time for Mozambique to
consider comprehensive and integrated harm reduction
programs and policies that focus on youth PWID to
reduce the high-risk sexual and drug use behaviors that
contribute to the growing HIV epidemic in the country.
Effective interventions in this young generation may pro-
tect the public health investments for adults in the future.
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